Neuroprotection: further evidence for the early and universal use of hydroxyurea in children with sickle cell disease. Karkoska K. Br J Haematol 2021;195:158-159.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Karkoska K. Neuroprotection: further evidence for the early and universal use of hydroxyurea in children with sickle cell disease. Br J Haematol 2021;195:158-159.
PMID: 34340262